Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021345 (
infectious mononucleosis
)
3,358
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
X-linked lymphoproliferative disease (XLP) is a rare primary immunodeficiency. Affected individuals usually present with the Epstein-Barr virus infection and have no apparent disease prior to presentation. The most common clinical manifestations are fulminant
infectious mononucleosis
, dysgammaglobulinaemia, and lymphoma (usually of B-cell origin). XLP is caused by mutations in the
SH2D1A
gene which encodes the intracellular adaptor molecule
SAP
(signalling lymphocyte activation molecule- (SLAM-) associated protein).
SAP
is predominantly expressed in T cells and NK cells and functions to regulate signal transduction pathways downstream of the SLAM family of surface receptors to control CD4+ T cell (and by extension B-cell), CD8+ T cell and NK cell function, and development of NKT cells. Thus,
SAP
mutations cause dysregulation of the immune system, with defects in both cellular and humoral immunity. Here we report two clinical cases of three patients who presented with different manifestations of XLP, namely, fulminant
infectious mononucleosis
, Burkitt lymphoma and hypogammaglobulinaemia.
...
PMID:X-Linked Lymphoproliferative Disease in Latvia: A Report of Two Clinically Distinct Cases. 3277 86
<< Previous
1
2
3